Biclonal IGHV IGHV ‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax

Jain Preetesh; Kanagal‐Shamanna Rashmi; Konoplev Sergej; Zuo Zhuang; Estrov Zeev

首页> 外文期刊>American Journal of Hematology >Biclonal IGHV IGHV ‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax

【24h】

Biclonal IGHV IGHV ‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax

机译：Biclonal Ighv Ighv -4-34毛细胞白血病变异和CLL - 用Ibrutinib和venetoclax成功治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Journal of Hematology》 |2018年第12期|共2页
作者
Jain Preetesh; Kanagal‐Shamanna Rashmi; Konoplev Sergej; Zuo Zhuang; Estrov Zeev;
展开▼
作者单位

Division of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHouston Texas;

Hematopathology The University of Texas MD Anderson Cancer CenterHouston Texas;

Hematopathology The University of Texas MD Anderson Cancer CenterHouston Texas;

Hematopathology The University of Texas MD Anderson Cancer CenterHouston Texas;

Leukemia The University of Texas MD Anderson Cancer CenterHouston Texas;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Biclonal IGHV IGHV ‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax [J] . Jain Preetesh, Kanagal‐Shamanna Rashmi, Konoplev Sergej, American Journal of Hematology . 2018,第12期

机译：Biclonal Ighv Ighv -4-34毛细胞白血病变异和CLL - 用Ibrutinib和venetoclax成功治疗
2. Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity? [J] . Jain Preetesh, Ok Chi Young, Konoplev Sergej, Journal of Clinical Oncology . 2016,第7期

机译：复发性难治性BRAF阴性，IGHV4-34阳性毛细胞白血病变异：不同的实体？
3. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias [J] . WaterfallJ.J., AronsE., WalkerR.L., Nature Genetics . 2014,第1期

机译：在变异和表达IGHV4-34的毛细胞白血病中MAP2K1突变的高患病率
4. Detection of de novo IGHV mutations by ultra-deep sequencing from in vitro activated B-cell chronic lymphocytic leukemia cells: Evidence for activation-induced deaminase function [C] . Chu C.C., Patten P.E.M., MacCarthy T, International Congress of Immunology. . 2014

机译：通过来自体外活化B细胞慢性淋巴细胞白血病细胞超深序的De Novo IghV突变检测：活化诱导的脱氨酶功能的证据
5. Therapeutic targeting of Hairy and Enhancer of Split 1 (HES1) transcriptional programs in T-cell Acute Lymphoblastic Leukemia [D] . Schnell, Stephanie A. 2015

机译：在T细胞急性淋巴细胞白血病中针对毛发和Split 1（HES1）转录增强子的治疗靶向
6. Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation [O] . Liqiang Xi, Evgeny Arons, Winnifred Navarro, -1

机译：表达变体和表达IGHV4-34的毛细胞白血病均缺乏BRAF V600E突变
7. Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes. [O] . Nicola J Weston-Bell, Francesco Forconi, Hanneke C Kluin-Nelemans, 2014

机译：变体B细胞受体同种型功能在具有突变的BRaF和IGHV基因的毛细胞白血病中不同。

Biclonal IGHV IGHV ‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax

著录项

相似文献

相关主题

期刊订阅